Chemours (NYSE:CC) CFO Acquires $50,049.00 in Stock

The Chemours Company (NYSE:CC) CFO Shane Hostetter purchased 3,350 shares of the business’s stock in a transaction on Thursday, August 6th. The shares were bought at an average cost of $14.94 per share, with a total value of $50,049.00. Following the acquisition, the chief financial officer directly owned 102,698 shares of the company’s stock, valued at $1,534,308.12. This trade represents a 3.37% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Chemours Price Performance

NYSE CC opened at $15.26 on Thursday. The Chemours Company has a 12 month low of $10.44 and a 12 month high of $28.67. The stock has a market cap of $2.30 billion, a price-to-earnings ratio of -7.99 and a beta of 1.43. The company’s 50 day moving average is $18.76 and its two-hundred day moving average is $20.03. The company has a current ratio of 1.66, a quick ratio of 0.88 and a debt-to-equity ratio of 18.98.

Chemours (NYSE:CC) last posted its quarterly earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 earnings per share for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.07). The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.65 billion. Chemours had a positive return on equity of 60.64% and a negative net margin of 5.00%.The business’s revenue for the quarter was down 1.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($2.54) earnings per share. As a group, research analysts anticipate that The Chemours Company will post 0.88 earnings per share for the current year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Friday, August 14th will be issued a $0.0875 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $0.35 annualized dividend and a yield of 2.3%. Chemours’s dividend payout ratio is currently -18.32%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Atlas Capital Advisors Inc. bought a new stake in shares of Chemours in the fourth quarter worth about $26,000. Aster Capital Management DIFC Ltd bought a new position in Chemours during the fourth quarter valued at approximately $28,000. Covestor Ltd grew its holdings in Chemours by 204.7% during the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock valued at $31,000 after buying an additional 1,748 shares in the last quarter. Eurizon Capital SGR S.p.A. purchased a new position in shares of Chemours in the fourth quarter valued at $31,000. Finally, Rothschild Investment LLC raised its position in shares of Chemours by 87.0% during the 4th quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 1,255 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Analyst Upgrades and Downgrades

CC has been the topic of several research analyst reports. Zacks Research upgraded Chemours from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. Morgan Stanley set a $18.00 target price on Chemours in a research report on Monday. Mizuho set a $22.00 target price on Chemours in a research note on Wednesday, August 5th. Weiss Ratings cut Chemours from a “sell (d)” rating to a “sell (d-)” rating in a report on Thursday, August 6th. Finally, Royal Bank Of Canada dropped their price target on Chemours from $26.00 to $22.00 and set an “outperform” rating for the company in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.00.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.